1. Home
  2. MP vs BIO Comparison

MP vs BIO Comparison

Compare MP & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MP Materials Corp.

MP

MP Materials Corp.

HOLD

Current Price

$68.72

Market Cap

9.0B

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$314.16

Market Cap

8.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MP
BIO
Founded
2017
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Laboratory Analytical Instruments
Sector
Basic Materials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
8.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MP
BIO
Price
$68.72
$314.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
4
Target Price
$70.92
$358.50
AVG Volume (30 Days)
7.8M
185.7K
Earning Date
02-19-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$232,742,000.00
$2,557,500,000.00
Revenue This Year
$34.68
$1.62
Revenue Next Year
$137.40
$2.26
P/E Ratio
N/A
N/A
Revenue Growth
26.44
N/A
52 Week Low
$18.64
$211.43
52 Week High
$100.25
$373.69

Technical Indicators

Market Signals
Indicator
MP
BIO
Relative Strength Index (RSI) 65.02 50.47
Support Level $62.20 $316.57
Resistance Level $70.07 $328.56
Average True Range (ATR) 3.73 8.58
MACD 1.58 0.74
Stochastic Oscillator 94.24 52.38

Price Performance

Historical Comparison
MP
BIO

About MP MP Materials Corp.

MP Materials Corp is the producer of rare earth materials in the Western Hemisphere. The company owns and operates the Mountain Pass Rare Earth Mine and Processing Facility, the only rare earth mining and processing site of scale in North America. The company is also developing a rare earth metal, alloy, and magnet manufacturing facility in Fort Worth, Texas. The company's operations are organized into two reportable segments: Materials and Magnetics.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: